Cargando…
Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability
Batch-to-batch pharmacokinetic (PK) variability of orally inhaled drug products has been documented and can render single-batch PK bioequivalence (BE) studies unreliable; results from one batch may not be consistent with a repeated study using a different batch, yet the goal of PK BE is to deliver a...
Autores principales: | Burmeister Getz, Elise, Carroll, Kevin J., Christopher, J. David, Morgan, Beth, Haughie, Scott, Cavecchi, Alessandro, Wiggenhorn, Christopher, Beresford, Hayden, Strickland, Helen, Lyapustina, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376725/ https://www.ncbi.nlm.nih.gov/pubmed/34410557 http://dx.doi.org/10.1208/s12249-021-02063-1 |
Ejemplares similares
-
Batch‐to‐batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial
por: Burmeister Getz, E, et al.
Publicado: (2016) -
Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability
por: Bodin, Jonathan, et al.
Publicado: (2020) -
Between‐Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial
por: Burmeister Getz, E, et al.
Publicado: (2016) -
Characterization of Nanoparticle Batch-To-Batch Variability
por: Mülhopt, Sonja, et al.
Publicado: (2018) -
Batch By Batch Longitudinal Emittance Blowup MD
por: Mastoridis, T, et al.
Publicado: (2012)